Evidence map›Paper›PMID 41436358›Full record

ArticleNMR in biomedicine2026

Detection Limits of Blood Metabolites at Physiological Concentrations Using Benchtop

Alexander D Hill, Gil Travish, Marie Phelan, Morgan Hayward, Carsten P Welsch

Abstract read
In one paragraph

Article in NMR in biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander D HillDepartment of Physics, University of Liverpool, Liverpool, UK.ORCID https://orcid.org/0000-0003-3460-6441
Gil TravishViBo Health Inc., Los Alamos, New Mexico, USA.
Marie PhelanDepartment of Biochemistry and Systems Biology, Institute of Systems Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Morgan HaywardDepartment of Molecular and Cell Biology, Leicester Institute of Structural and Chemical Biology, University of Leicester, Leicester, UK.
Carsten P WelschDepartment of Physics, University of Liverpool, Liverpool, UK.

Funding

Medical Research Council MR/V000950/1Science and Technology Facilities Council ST/W006766/1
6 · The paper itself

Abstract

Commercial low-field (LF) magnetic resonance spectroscopy (MRS) offers a route to rapid and repeated in vivo metabolite tracking; however, its sensitivity and interpretability at physiological concentrations remain underexplored. Here, we evaluate the performance of an 80-MHz benchtop nuclear magnetic resonance (NMR) spectrometer (Bruker Fourier 80) across several key blood metabolites at physiological concentrations, ranging between 0.05 and 10.0 mmol/L. We characterise the relationship between metabolite concentration, acquisition time and signal-to-noise ratio (SNR) for multiple pulse sequences and assess how the choice of SNR definition influences reported detection and quantification thresholds. Metabolites present at millimolar levels, such as glucose and lactate, were readily detectable within 20 s, with the water-suppressing wet pulse sequence yielding the highest SNR at fixed acquisition time. Concentration differences were also readily distinguishable. In contrast, submillimolar metabolites such as citrate require over 4 min to reach conventional detection thresholds, constraining their applicability to rapid metabolite tracking via MRS. To address interpretability in low-SNR data, we introduce a template-fitting approach based on simulated standards from CcpNMR AnalysisAssign, which stabilised relative metabolite quantification under low-SNR conditions. These results establish quantitative benchmarks for LF NMR metabolite detection and demonstrate how simulation-assisted analysis can extend its utility. These findings inform both the selection of target metabolites and optimisation strategies for emerging commercial in vivo MRS devices, including the DigiScan

Indexed as

Limit of DetectionMetabolomeHumansMagnetic Resonance SpectroscopySignal-To-Noise Ratioapplicationslow‐field NMRmetabolic trackingmetabolomicsmethods and engineeringMRSpersonalised healthcarepostacquisition processing

Identifiers

PMID41436358
PMCPMC12727471

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.